[ASND] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
28-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -80.86%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 6,953 13,375 10,581 1,530 4,606 8,118 13,983 -10.98%
PBT -419,174 -218,250 -130,491 -124,374 -68,732 -33,574 -10,340 85.23%
Tax -219 -234 -394 -477 -227 -652 -682 -17.23%
NP -418,955 -218,016 -130,097 -123,897 -68,505 -32,922 -9,658 87.34%
Tax Rate - - - - - - - -
Total Cost 425,908 231,391 140,678 125,427 73,111 41,040 23,641 61.83%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -6,025.53 -1,630.03 -1,229.53 -8,097.84 -1,487.30 -405.54 -69.07 110.45%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -8.28 -4.69 -3.17 -3.68 -2.58 -1.39 -0.57 56.14%
EPS Diluted -8.28 -4.69 -3.17 -3.68 -2.58 -1.39 -0.57 56.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.